Cynosure reports Q4 revenue growth, laser highlights

Cynosure reported financial results for its fourth quarter and 12 months ending Dec. 31, 2014, with fourth quarter revenue up 16% year-over-year to $86.3 million and full-year 2014 revenue of $292.4 million, up 29%.

Demand for PicoSure, Cynosure’s flagship picosecond laser, was a “key driver” of its North American laser business, up 29% in the fourth quarter of 2014 from a year earlier, according to a company press release.

Other highlights in the quarterly report included:

Cynosure recently submitted to the FDA, 2 months ahead of schedule, the 510(k) premarket notification of a 1060 nm laser for the non-invasive reduction of fat, supported by clinical data from approximately 100 patients treated with the device. Cynosure’s goal is to introduce the product in the second half of 2015, according to the release.
An exclusive agreement was reached between Cynosure and El.En. S.p.A. to market and distribute the MonaLisa Touch, a carbon dioxide laser for the treatment of vaginal atrophy, in North America. The product was launched by Cynosure in January.

Reference: www.cynosure.com